Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -510.97%-1.04M | -38.89%-2M | -419.88%-1.71M | 152.65%2.84M | 893.20%3.91M | 40.93%-170.82K | 23.77%-1.44M | 114.82%533.86K | -10.47%-5.39M | 113.36%393.79K |
| Net income from continuing operations | -214.78%-660.07K | -132.14%-624.44K | 54.71%-684.03K | 126.77%1.59M | 116.28%581.09K | -14.98%575.08K | 241.27%1.94M | 9.39%-1.51M | 37.85%-5.93M | -0.33%-3.57M |
| Operating gains losses | 147.02%345.64K | 94.79%-193.43K | -70.85%235.3K | 10.24%-2.28M | 10.43%1.37M | 68.22%-735.08K | -293.32%-3.71M | 123.88%807.2K | -19.92%-2.54M | 167.20%1.24M |
| Depreciation and amortization | -21.07%373.56K | -26.64%392.32K | -38.46%386.74K | -12.89%2.19M | -26.42%557.18K | -21.26%473.28K | -9.96%534.79K | 11.01%628.45K | 48.17%2.52M | 21.60%757.2K |
| Asset impairment expenditure | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- | -90.73%241.07K | --0 |
| Remuneration paid in stock | 706.09%676.39K | 130.51%123.91K | 96.83%108.85K | -47.59%269.14K | -25.57%76.17K | -65.25%83.91K | -43.97%53.76K | -25.03%55.3K | 1.10%513.52K | -62.19%102.33K |
| Deferred tax | 124.53%168.85K | -65.08%386.05K | 34.82%740.96K | 372.71%2.25M | 244.04%518.09K | 39.59%75.2K | 119.74%1.11M | 97.47%549.58K | 187.66%475.66K | -250.26%-359.69K |
| Other non cashItems | 676.60%199.29K | -38.73%435.15K | 436.84%871.37K | -13.52%3.2M | 38.42%2.37M | -106.73%-34.56K | -4.91%710.21K | -77.92%162.31K | 301.41%3.7M | 74.34%1.71M |
| Change In working capital | -252.81%-2.15M | -21.53%-2.52M | -2,021.79%-3.37M | -0.55%-4.39M | -400.33%-1.55M | -1,043.57%-608.64K | 55.19%-2.07M | 23.65%-158.68K | -372.93%-4.37M | 126.89%516.89K |
| -Change in receivables | 78.13%-525.86K | -142.09%-611.77K | -11.04%-2.69M | -512.43%-5.08M | -470.14%-1.71M | -248.85%-2.4M | 70.24%1.45M | -158.49%-2.42M | 118.47%1.23M | -533.62%-300.6K |
| -Change in prepaid assets | -102.54%-5.39K | -168.29%-12.21K | 5,420.75%578.21K | -288.37%-437.3K | 58.88%-656.89K | -79.09%212.58K | -95.82%17.87K | -102.82%-10.87K | 1,192.74%232.15K | -1,216.41%-1.6M |
| -Change in payables and accrued expense | -150.82%-1.06M | 56.52%-1.17M | -146.05%-446.02K | 99.79%-8.42K | -150.98%-379.72K | 653.55%2.09M | 64.00%-2.69M | -58.60%968.55K | -2,395.80%-4.1M | 142.27%744.92K |
| -Change in other current assets | 95.40%-25.55K | 104.47%26.55K | -16.74%-131.61K | -268.41%-252.79K | 118.54%1.01M | -78.31%-555.62K | -681.28%-593.42K | -10.44%-112.74K | --150.1K | --461.71K |
| -Change in other working capital | -1,151.48%-528.9K | -185.37%-752.72K | -148.10%-681.07K | 173.88%1.39M | -84.36%189.06K | 101.90%50.3K | -118.14%-263.76K | 174.72%1.42M | -324.33%-1.88M | 573.05%1.21M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -510.97%-1.04M | -38.89%-2M | -419.88%-1.71M | 152.65%2.84M | 893.20%3.91M | 40.93%-170.82K | 23.77%-1.44M | 114.82%533.86K | -10.47%-5.39M | 113.36%393.79K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -58.38%-280.33K | -119.64%-1.17M | 1,031.26%3.32M | 590.12%2.37M | -157.01%-3.08M | -134.30%-177K | 1,092.62%5.98M | -121.91%-356.4K | 103.18%343.37K | 79.62%-1.2M |
| Net PPE purchase and sale | ---9.26K | ---- | ---- | 5.16%-71.81K | -275.65%-71.81K | --0 | --0 | --0 | 53.31%-75.72K | 130.13%40.88K |
| Net intangibles purchas and sale | ---116.52K | ---- | ---- | ---- | ---- | --0 | ---- | --0 | ---- | ---- |
| Net business purchase and sale | 64.18%-345K | 76.81%-190K | -221.66%-759.12K | 30.77%-3.63M | -5.29%-1.61M | ---963.18K | -2,583.06%-819.46K | 93.59%-236K | 7.94%-5.24M | -96.57%-1.53M |
| Net investment purchase and sale | -20.45%190.45K | -835.72%-3.31M | 3,487.19%4.08M | -608.35%-1.47M | ---2.04M | --239.41K | 185.89%450.53K | -162.38%-120.4K | 25.85%289.45K | ---- |
| Net other investing changes | --0 | ---- | ---- | 40.44%7.54M | --645K | 148.53%546.77K | ---- | ---- | 204.27%5.37M | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -58.38%-280.33K | -119.64%-1.17M | 1,031.26%3.32M | 590.12%2.37M | -157.01%-3.08M | -134.30%-177K | 1,092.62%5.98M | -121.91%-356.4K | 103.18%343.37K | 79.62%-1.2M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 42.22%-414.33K | 219.52%3.86M | 37.18%-627.42K | -268.14%-5.53M | -342.59%-576.49K | 23.57%-717.05K | -405.43%-3.23M | -134.11%-998.83K | -69.34%3.29M | -97.63%237.64K |
| Net issuance payments of debt | 25.36%-535.19K | 219.49%3.86M | 37.18%-627.42K | -6,889.67%-5.53M | -133.75%-576.49K | 23.57%-717.05K | -52.72%-3.23M | -129.52%-998.83K | -99.29%81.39K | -102.28%-246.62K |
| Net common stock issuance | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash dividends paid | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --0 | --0 |
| Proceeds from stock option exercised by employees | --120.86K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Interest paid (cash flow from financing activities) | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- | ---168K | ---96K |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---963.18K | -555.57%-819.46K | 48.16%-236K | 541.01%3.37M | --3.95M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 42.22%-414.33K | 219.52%3.86M | 37.18%-627.42K | -268.14%-5.53M | -342.59%-576.49K | 23.57%-717.05K | -405.43%-3.23M | -134.11%-998.83K | -69.34%3.29M | -97.63%237.64K |
| Net cash flow | ||||||||||
| Beginning cash position | 33.23%4.36M | 85.20%3.62M | -7.09%2.58M | -27.16%2.77M | -37.69%2.26M | -3.56%3.27M | -59.68%1.95M | -27.16%2.77M | -58.16%3.81M | 29.02%3.63M |
| Current changes in cash | -63.24%-1.74M | -47.01%692.04K | 219.78%983.85K | 81.71%-321.11K | 145.84%259.12K | -49.69%-1.06M | 191.25%1.31M | -186.23%-821.36K | 64.65%-1.76M | -146.28%-565.23K |
| Effect of exchange rate changes | -114.57%-8.58K | 335.22%47.65K | 25,806.51%55.7K | -82.73%124.48K | 118.50%54.44K | -93.83%58.88K | 150.28%10.95K | -99.74%215 | 319.14%720.64K | -28.53%-294.26K |
| End cash Position | 15.28%2.61M | 33.23%4.36M | 85.20%3.62M | -7.09%2.58M | -7.09%2.58M | -37.69%2.26M | -3.56%3.27M | -59.68%1.95M | -27.16%2.77M | -27.16%2.77M |
| Free cash from | -584.60%-1.17M | -66.81%-2.4M | -419.88%-1.71M | 150.60%2.76M | 783.27%3.84M | 47.40%-170.82K | 25.63%-1.44M | 114.68%533.86K | -7.55%-5.46M | 113.91%434.67K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.